BML Investment Partners Amends AVROBIO Stake, Signals Reduced Ownership

Ticker: TECX · Form: SC 13G/A · Filed: Feb 7, 2024 · CIK: 1681087

Avrobio, Inc. SC 13G/A Filing Summary
FieldDetail
CompanyAvrobio, Inc. (TECX)
Form TypeSC 13G/A
Filed DateFeb 7, 2024
Risk Levelmedium
Pages3
Reading Time4 min
Key Dollar Amounts$0.0001
Sentimentbearish

Complexity: simple

Sentiment: bearish

Topics: institutional-ownership, ownership-change, amendment, biotech

TL;DR

**BML Investment Partners is out of AVROBIO, watch for potential stock dip.**

AI Summary

BML Investment Partners, L.P. filed an amended Schedule 13G/A on February 7, 2024, indicating a change in their beneficial ownership of AVROBIO, Inc. common stock as of December 31, 2023. This filing, an amendment to a previous disclosure, signals that BML Investment Partners, L.P. is no longer required to report their holdings under Rule 13d-1(c), suggesting their stake has fallen below the 5% threshold or they are no longer an active investor. This matters to shareholders because a significant institutional investor reducing their stake could be interpreted as a loss of confidence in AVROBIO's future prospects, potentially impacting the stock price.

Why It Matters

A major institutional investor, BML Investment Partners, L.P., has likely reduced its stake in AVROBIO, Inc., which could signal a lack of confidence and potentially pressure the stock price.

Risk Assessment

Risk Level: medium — The reduction in a significant institutional holding can create selling pressure and negatively impact investor sentiment for AVROBIO, Inc.

Analyst Insight

An investor considering AVROBIO, Inc. should investigate the reasons behind BML Investment Partners, L.P.'s reduced stake and assess if other institutional investors are also divesting, as this could signal underlying issues or a lack of confidence.

Key Numbers

  • 05455M100 — CUSIP Number (identifies AVROBIO, Inc. common stock)
  • 1 — Amendment Number (indicates this is an amendment to a previous filing)

Key Players & Entities

  • BML Investment Partners, L.P. (company) — the reporting person who filed the SC 13G/A
  • AVROBIO, Inc. (company) — the subject company whose stock is being reported
  • December 31, 2023 (date) — the date of the event requiring the filing
  • February 7, 2024 (date) — the filing date of the SC 13G/A
  • $0.0001 (dollar_amount) — par value per share of AVROBIO common stock

Forward-Looking Statements

  • AVROBIO's stock price may experience downward pressure in the short term. (AVROBIO, Inc.) — medium confidence, target: Q1 2024
  • Other institutional investors may re-evaluate their positions in AVROBIO. (AVROBIO, Inc.) — low confidence, target: Q2 2024

FAQ

What type of filing is this document?

This document is an SC 13G/A, which is an amendment to a Schedule 13G filing, as stated in the 'FORM TYPE: SC 13G/A' and 'SCHEDULE 13G/A*' sections.

Who is the subject company of this filing?

The subject company is AVROBIO, Inc., as indicated under 'SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: AVROBIO, Inc.'.

Who is the reporting person in this filing?

The reporting person is BML Investment Partners, L.P., as stated under 'FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: BML Investment Partners, L.P.' and '1 NAMES OF REPORTING PERSONS BML Investment Partners, L.P.'.

What was the date of the event that required this filing?

The date of the event which required this filing was December 31, 2023, as specified under '(Date of Event Which Requires Filing of this Statement) Decenber 31, 2023'.

Under which rule was this Schedule 13G/A filed?

This Schedule 13G/A was filed under Rule 13d-1(c), as indicated by the checked box '☒ Rule 13d-1(c)'.

Filing Stats: 980 words · 4 min read · ~3 pages · Grade level 8.3 · Accepted 2024-02-07 10:32:34

Key Financial Figures

  • $0.0001 — ame of Issuer) Common Stock, par value $0.0001 per share (Title of Class of Securiti

Filing Documents

(a)

Item 1(a). Name of Issuer: AVROBIO, Inc.

(b)

Item 1(b). Address of Issuer's Principal Executive Offices: 100 Technology Square, Sixth Floor, Cambridge, MA 02139

(a)

Item 2(a). Name of Person Filing: BML Investment Partners, L.P.

(b)

Item 2(b). Address of Principal Business Office or, if none, Residence: 65 E Cedar, Suite 2 Zionsville, IN 46077

(c)

Item 2(c). Citizenship: Delaware

(d)

Item 2(d). Title of Class of Securities: Common Stock, par value $0.0001 per share

(e)

Item 2(e). CUSIP Number: 05455M100 Item 3. If This Statement Is Filed Pursuant to Sections 240.13d-1(b) or 240.13d-2(b) or (c), Check Whether the Person Filing Is a(n): (a) Broker or dealer registered under Section 15 of the Act (15 U.S.C. 78o); (b) Bank as defined in Section 3(a)(6) of the Act (15 U.S.C. 78c); (c) Insurance company as defined in Section 3(a)(19) of the Act (15 U.S.C. 78c); (d) Investment company registered under Section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8); (e) Investment adviser in accordance with Section 240.13d-1(b)(1)(ii)(E); (f) Employee benefit plan or endowment fund in accordance with Section 240.13d-1(b)(1)(ii)(F); (g) Parent holding company or control person in accordance with Section 240.13d-1(b)(1)(ii)(G); (h) Savings association as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813); (i) Church plan that is excluded from the definition of an investment company under Section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3); (j) A non-U.S. institution in accordance with Section 240.13d-1(b)(1)(ii)(J); (k) Group, in accordance with Section 240.13d-1(b)(1)(ii)(K). If filing as a non-U.S. institution in accordance with Section 240.13d-1(b)(1)(ii)(J), please specify the type of institution: ____________________________ . Item 4. (a) Amount beneficially owned: 4,401,627 (b) Percent of class: 9.9 (c) Number of shares as to which the person has: (i) Sole power to vote or to direct the vote: 400,000 (ii) Shared power to vote or to direct the vote: 4,401,627 (iii) Sole power to dispose or to direct the disposition of: 400,000 (iv) Shared power to dispose or to direct the disposition of: 4,401,627 Item 5. If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent o

View Full Filing

View this SC 13G/A filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.